Study results using a quality-by-design method, risk-based monitoring, and real-time direct data entry.
Judith M. Schloss Markowitz
Advertisement
MS, Senior Project Manager (jmarkowitz@targethealth.com
Articles by Judith M. Schloss Markowitz
Advertisement
Latest Updated Articles
Three-Pronged Approach to Optimizing Trial MonitoringPublished: June 1st 2014 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
2
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
3
Reducing Site Burden Through Better Technology Integration in Clinical Trials
4
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
